
Anthropic reportedly told investors it plans to prioritize AI in healthcare and biology to help "mitigate some of the negative sentiment around AI"
Anthropic is racing toward what could be the biggest IPO ever this fall, but it’s facing real headwinds.
Investors are grilling the company on rising competition from cheaper Chinese models, tensions with the Trump administration, and backlash over power-hungry data centers.
As it pitches its rapid growth and popular coding tool Claude Code, the company is also leaning into a different story: using its models in healthcare and biology.
By highlighting potential breakthroughs in medicine and science, Anthropic is betting that life-changing applications of AI can help shift the narrative from hype and risk to positive real-world impact.